mcK6A1 is an inhibitor for the aggregation of amyloid-beta (Abeta), that selectively binds to the 16KLVFFA21 segment of Abeta42, forms an extended beta-folded structure, and inhibits the formation of Abeta42 oligomers. mcK6A1 can be used in research of Alzheimers disease and other amyloid-related diseases[1].
Molekulargewicht:
1446.65
Formel:
C71H99N17O16
Target-Kategorie:
Amyloid-beta
Anwendungsbeschreibung:
Peptides
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
